52.1. The Minister may make agreements with drug manufacturers for the purpose of funding activities to promote improved use of medications.
The Minister may also make the following agreements with drug manufacturers:
(1) financial risk-sharing agreements for specific medications; and
(2) agreements providing for compensatory measures to mitigate the negative impact of a price increase on the public plan.
The agreements may specify, among other particulars, the sums of money the manufacturers undertake to pay and those that may be added by the Minister, as well as the manner in which the sums are to be managed.
2002, c. 27, s. 15; 2005, c. 40, s. 18.